Combating antimicrobial resistance in ESBL- and AmpC-producing Enterobacterales: In vitro evaluation of cefepime-enmetazobactam
{{output}}
Purpose: To evaluate the in-vitro activity of cefepime-enmetazobactam (FEP-EMT)-a novel β-lactam-β-lactamase inhibitor (BL/BLI) combination against Extended-spectrum β-lactamase (ESBL)- and AmpC β-lactamase (AmpC)- producing ... ...
